Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute …

SR Mehta, JF Tanguay, JW Eikelboom, SS Jolly… - The Lancet, 2010 - thelancet.com
Background Clopidogrel and aspirin are the most commonly used antiplatelet therapies for
percutaneous coronary intervention (PCI). We assessed the effect of various clopidogrel and …
被引用次数：1123 相关文章

Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute …

SR Mehta, JF Tanguay, JW Eikelboom, SS Jolly… - The Lancet, 2010 - infona.pl
Clopidogrel and aspirin are the most commonly used antiplatelet therapies for percutaneous
coronary intervention (PCI). We assessed the effect of various clopidogrel and aspirin …

Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute …

SR Mehta, S Polić - The Lancet, 2010 - croris.hr
Sažetak Clopidogrel and aspirin are the most commonly used antiplatelet therapies for
percutaneous coronary intervention (PCI). We assessed the effect of various clopidogrel and …

[引用][C] Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute …

SR Mehta, JF Tanguay, JW Eikelboom, SS Jolly… - The Lancet, 2010 - cir.nii.ac.jp
Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in
individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS …

[引用][C] Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute …

SR Mehta, JF Tanguay, JW Eikelboom, K Niemelä - Lancet, 2010 - researchportal.tuni.fi
Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in
individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS …

[引用][C] Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute …

SR Mehta, JF Tanguay, JW Eikelboom, S Jolly… - The …, 2010 - repositorio.usp.br
ReP USP - Detalhe do registro: Double-dose versus standard-dose clopidogrel and high-dose
versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute …

Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute …

S Mehta, J Tanguay, J Eikelboom, S Jolly, C Joyner… - THE LANCET, 2010 - arts.units.it
In patients undergoing PCI for acute coronary syndromes, a 7-day double-dose clopidogrel
regimen was associated with a reduction in cardiovascular events and stent thrombosis …

Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute …

SR Mehta, JF Tanguay, JW Eikelboom, SS Jolly… - 2010 - ricerca.unityfvg.it
In patients undergoing PCI for acute coronary syndromes, a 7-day double-dose clopidogrel
regimen was associated with a reduction in cardiovascular events and stent thrombosis …

Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute …

SR Mehta, JF Tanguay, JW Eikelboom… - Lancet (London …, 2010 - europepmc.org
Background Clopidogrel and aspirin are the most commonly used antiplatelet therapies for
percutaneous coronary intervention (PCI). We assessed the effect of various clopidogrel and …

Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute …

SR Mehta, JF Tanguay, JW Eikelboom, SS Jolly… - 2010 - pubmed.ncbi.nlm.nih.gov
Background Clopidogrel and aspirin are the most commonly used antiplatelet therapies for
percutaneous coronary intervention (PCI). We assessed the effect of various clopidogrel and …